🎗️ Oncology Papers

Scholarly works matching "oncology" in Crossref, sorted by the number of times other DOI-registered works cite them. Citation counts come from Crossref and are usually lower than Google Scholar figures.

575 top-cited papers indexed

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Antonio C. Wolff, M. Elizabeth H. Hammond et al. (2013)

Journal of Clinical Oncology

3.5K citesjournal articlePDF

Tumour heterogeneity and resistance to cancer therapies

Ibiayi Dagogo-Jack, Alice T. Shaw (2017)

Nature Reviews Clinical Oncology

3.6K citesjournal articlePDF

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

Tetsuya Mitsudomi, Satoshi Morita et al. (2010)

The Lancet Oncology

3.3K citesjournal articlePDF

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

Caicun Zhou, Yi-Long Wu et al. (2011)

The Lancet Oncology

3.3K citesjournal articlePDF

Clinical development and potential of photothermal and photodynamic therapies for cancer

Xingshu Li, Jonathan F. Lovell et al. (2020)

Nature Reviews Clinical Oncology

3.4K citesjournal articlePDF

mixOmics: An R package for ‘omics feature selection and multiple data integration

Florian Rohart, Benoît Gautier et al. (2017)

PLOS Computational Biology

3.6K citesjournal articlePDF

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

Anil K. Chaturvedi, Eric A. Engels et al. (2011)

Journal of Clinical Oncology

3.2K citesjournal articlePDF

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Julie R. Brahmer, Christina Lacchetti et al. (2018)

Journal of Clinical Oncology

3.2K citesjournal articlePDF

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

A. Goldhirsch, E.P. Winer et al. (2013)

Annals of Oncology

3.1K citesjournal articlePDF

Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

A. de Gramont, A. Figer et al. (2000)

Journal of Clinical Oncology

3.1K citesjournal articlePDF

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

A. Goldhirsch, W.C. Wood et al. (2011)

Annals of Oncology

3.1K citesjournal articlePDF

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

Global Burden of Disease Cancer Collaboration, Christina Fitzmaurice et al. (2017)

JAMA Oncology

3.1K citesjournal articlePDF

Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

Arvind Dasari, Chan Shen et al. (2017)

JAMA Oncology

3.1K citesjournal articlePDF

Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients

John P. Stein, Gary Lieskovsky et al. (2001)

Journal of Clinical Oncology

3.0K citesjournal articlePDF

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Malcolm J. Moore, David Goldstein et al. (2007)

Journal of Clinical Oncology

3.0K citesjournal articlePDF